fda glp-1 compounding crackdown news today New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our National Hispanic Medical Association |
Description
Tirzepatide activates two: GLP-1, which slows digestion and helps regulate appetite, and GIP, which influences how your body responds to insulin and stores energy
We identified 689 neuroendocrine neoplasms, including pancreatic neuroendocrine tumors (PanNETs) and neuroendocrine neoplasms originating from non-pancreatic sites, and performed GLP- 1R immunostaining
In an interview I did in 2024 with Bloomberg (Canada), I talked about how GLP-1s were reshaping other consumer-facing business sectors beyond medical and health care from hospitality and airlines to mobility, consumer goods and clothing
High cholesterol and excess weight often travel together, creating compounded heart disease risk
Weight loss drugs have surged in popularity in recent years, transforming the pharmaceutical landscape
Our facility provides swift medical assistance as an alternative to the ER for non-life threatening conditions
